These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25511987)

  • 1. Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years.
    Grignolo S; Tatarelli P; Gustinetti G; Viazzi F; Bonino B; Maggi P; Viscoli C; Di Biagio A
    Eur J Pediatr; 2015 Jun; 174(6):843-6. PubMed ID: 25511987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
    Huang YS; Chan CK; Tsai MS; Lee KY; Lin SW; Chang SY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2017 Oct; 50(5):595-603. PubMed ID: 26514942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
    Nishijima T; Kawasaki Y; Tanaka N; Mizushima D; Aoki T; Watanabe K; Kinai E; Honda H; Yazaki H; Tanuma J; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H; Oka S
    AIDS; 2014 Aug; 28(13):1903-10. PubMed ID: 25259702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial.
    Decloedt EH; Lesosky M; Maartens G; Joska JA
    AIDS Res Ther; 2017 Feb; 14(1):6. PubMed ID: 28160772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy.
    Nishijima T; Kurosawa T; Tanaka N; Kawasaki Y; Kikuchi Y; Oka S; Gatanaga H
    AIDS; 2016 Jun; 30(10):1563-71. PubMed ID: 26919734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profile and renal safety of tenofovir disoproxil fumarate-based anti-retroviral therapy in HIV-infected Chinese patients.
    Yang J; Chen J; Ji Y; Tang Q; Zhang R; Liu L; Shen Y; Xun J; Song W; Tang Y; Wang Z; Qi T; Lu H
    Int J Infect Dis; 2019 Jun; 83():64-71. PubMed ID: 30951879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.
    Rokx C; Alshangi H; Verbon A; Zietse R; Hoorn EJ; Rijnders BJ
    J Infect Dis; 2016 Feb; 213(4):561-8. PubMed ID: 26401025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
    De Beaudrap P; Diallo MB; Landman R; Guèye NF; Ndiaye I; Diouf A; Kane CT; Etard JF; Girard PM; Sow PS; Delaporte E;
    AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1221-7. PubMed ID: 20854202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2.
    Fafin C; Pugliese P; Durant J; Mondain V; Rahelinirina V; De Salvador F; Ceppi C; Perbost I; Rosenthal E; Roger PM; Cua E; Dellamonica P; Esnault V; Pradier C; Moranne O
    Nephron Clin Pract; 2012; 120(4):c205-14. PubMed ID: 23037894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
    Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM
    AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tenofovir dose adjustment on both estimated glomerular filtration rate and tenofovir trough concentration.
    Bregigeon S; Solas C; Faucher O; Obry-Roguet V; Tamalet C; Poizot-Martin I
    Antivir Ther; 2017; 22(6):529-533. PubMed ID: 28195560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients.
    Casado JL; Del Rey JM; Bañón S; Santiuste C; Rodriguez M; Moreno A; Perez-Elías MJ; Liaño F; Moreno S
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):416-22. PubMed ID: 26962850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.
    Pradat P; Le Pogam MA; Okon JB; Trolliet P; Miailhes P; Brochier C; Maynard M; Bailly F; Zoulim F; Cotte L
    J Viral Hepat; 2013 Sep; 20(9):650-7. PubMed ID: 23910650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Adverse Effects of Tenofovir Containing Regimens in HIV-Infected Children and Adolescents in North India.
    Kumar R; Singh MV; Shrivastava A; Yadav RK; Siddiqui SA; Sachan R; Maurya M; Mishra N; Shukla SK; Sonkar M
    Indian Pediatr; 2024 Apr; 61(4):337-342. PubMed ID: 38449277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen.
    Manosuthi W; Sukasem C; Thongyen S; Nilkamhang S; Sungkanuparph S
    J Antimicrob Chemother; 2014 Aug; 69(8):2195-201. PubMed ID: 24788661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
    Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study.
    Giacomet V; Nannini P; Vigano A; Erba P; Benincaso A; Bedogni G; Cattaneo D; Falvella FS; Zuccotti GV
    Clin Drug Investig; 2015 Jul; 35(7):419-26. PubMed ID: 26013475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents.
    Bunupuradah T; Phupitakphol T; Sophonphan J; Prasitsuebsai W; Anugulruengkitt S; Jantarabenjakul W; Sopa B; Ruxrungtham K; Chanakul A; Puthanakit T;
    Pediatr Infect Dis J; 2018 Jan; 37(1):66-70. PubMed ID: 28719505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing.
    Aurpibul L; Cressey TR; Sricharoenchai S; Wittawatmongkol O; Sirisanthana V; Phongsamart W; Sudjaritruk T; Chokephaibulkit K
    Pediatr Infect Dis J; 2015 Apr; 34(4):392-7. PubMed ID: 25760566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection.
    Sarteschi G; Di Biagio A; Focà E; Taramasso L; Bovis F; Celotti A; Mirabella M; Magnasco L; Mora S; Giacomini M; Bassetti M
    PLoS One; 2020; 15(10):e0240550. PubMed ID: 33057418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.